You are currently viewing a new version of our website. To view the old version click .

Pharmaceutics, Volume 16, Issue 11

November 2024 - 140 articles

Cover Story: This study explores the development of a self-microemulsifying drug delivery system (SMEDDS) suppository for ibuprofen (IBU) using semisolid extrusion (SSE) 3D printing. SSE 3D printing has produced various-sized suppositories that have been evaluated for physicochemical properties, content uniformity, and dissolution profiles. Characterization confirmed IBU’s amorphous state and nano-sized droplets, which enhance absorption. Dissolution tests revealed a superior initial release rate compared to IBU powder. This study demonstrates 3D printing's potential for creating customizable lipid-based suppositories to improve drug bioavailability and meet personalized patient needs. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (140)

  • Review
  • Open Access
6 Citations
5,281 Views
15 Pages

Recent technological advancements, including computer-assisted drug discovery, gene-editing techniques, and high-throughput screening approaches, have greatly expanded the palette of methods for the discovery of peptides available to researchers. The...

  • Article
  • Open Access
4,272 Views
19 Pages

Development and Evaluation of Lactose-Free Single-Unit and Multiple-Unit Preparations of a BCS Class II Drug, Rivaroxaban

  • Daniel Zakowiecki,
  • Peter Edinger,
  • Markos Papaioannou,
  • Michael Wagner,
  • Tobias Hess,
  • Jadwiga Paszkowska,
  • Marcela Staniszewska,
  • Daria Myslitska,
  • Michal Smolenski and
  • Justyna Dobosz
  • + 2 authors

Background/Objectives: The aim of the present study was to develop lactose-free formulations of rivaroxaban, a novel oral anticoagulant used for the treatment and prevention of blood clotting. As a BCS Class II drug, rivaroxaban is characterized by p...

  • Article
  • Open Access
1 Citations
1,499 Views
15 Pages

The Acid-Buffered Engineered Gel Promotes In Vitro Cutaneous Healing and Fights Resistant Bacteria in Wounds

  • Fatima Abid,
  • Emmeline Virgo,
  • Tahlia Louise Kennewell,
  • Riya Khetan,
  • Hanif Haidari,
  • Zlatko Kopecki,
  • Yunmei Song and
  • Sanjay Garg

Background: Treatment of cutaneous wound infections is becoming a major clinical challenge due to the growing problem of antimicrobial resistance associated with existing wound treatments. Two prevalent pathogens in wound infections, Staphylococcus a...

  • Article
  • Open Access
1 Citations
1,248 Views
25 Pages

Background/Objectives: In this paper, we created enteric delayed-release granules that load Dendrobine (DNL) directly into the intestinal flora of hyperlipidemic mice, based on the relationship between intestinal flora and hyperlipidemia. Methods: We...

  • Article
  • Open Access
1,436 Views
27 Pages

Future-Oriented Nanosystems Composed of Polyamidoamine Dendrimer and Biodegradable Polymers as an Anticancer Drug Carrier for Potential Targeted Treatment

  • Katarzyna Strzelecka,
  • Adam Kasiński,
  • Tadeusz Biela,
  • Anita Bocho-Janiszewska,
  • Anna Laskowska,
  • Łukasz Szeleszczuk,
  • Maciej Gawlak,
  • Marcin Sobczak and
  • Ewa Oledzka

Background/Objectives: Camptothecin (CPT) is a well-known chemical compound recognized for its significant anticancer properties. However, its clinical application remains limited due to challenges related to CPT’s high hydrophobicity and the i...

  • Article
  • Open Access
2,036 Views
14 Pages

PRIMERS: Polydopamine Radioimmunotherapy with Image-Guided Monitoring and Enhanced Release System

  • Shahinur Acter,
  • Lindokuhle M. Ngema,
  • Michele Moreau,
  • Debarghya China,
  • Akila Viswanathan,
  • Kai Ding,
  • Yahya E. Choonara,
  • Sayeda Yasmin-Karim and
  • Wilfred Ngwa

Background/Objectives: To overcome the side effects of conventional cancer treatment, multifunctional nanoparticles with image-guidance properties are increasingly desired to obtain enhanced therapeutic efficacy without any toxicity of the treatment....

  • Review
  • Open Access
3 Citations
3,746 Views
21 Pages

Nanotechnology in Pain Management

  • Andrew Torpey,
  • Emily Bellow,
  • Veronica Samojedny,
  • Sukhpreet Ahluwalia,
  • Amruta Desai,
  • William Caldwell and
  • Sergio Bergese

Chronic pain is a debilitating condition that affects millions of patients worldwide, contributing to a high disease burden and millions of dollars in lost wages, missed workdays, and healthcare costs. Opioids, NSAIDs, acetaminophen, gabapentinoids,...

  • Communication
  • Open Access
7 Citations
2,125 Views
9 Pages

Mechanical Characterization of Individual Needles in Microneedle Arrays: Factors Affecting Compression Test Results

  • Yusuke Tsuboko,
  • Hideyuki Sakoda,
  • Yoshihiro Okamoto,
  • Yusuke Nomura and
  • Eiichi Yamamoto

Background: This study aims to investigate the impact of test conditions on the results of the compression testing of microneedle arrays (MNAs). Methods: Uniaxial compression tests were conducted on polyglycolic acid-fabricated biodegradable MNAs. Lo...

  • Article
  • Open Access
1,642 Views
19 Pages

Antitubercular Activity of 7-Methyljuglone-Loaded Poly-(Lactide Co-Glycolide) Nanoparticles

  • Bianca Diedericks,
  • Anna-Mari Kok,
  • Vusani Mandiwana,
  • Bhavna Gowan Gordhan,
  • Bavesh Davandra Kana,
  • Suprakas Sinha Ray and
  • Namrita Lall

Background/Objectives: Loading of natural products into poly-(lactide-co-glycolic) acid (PLGA) nanoparticles as drug delivery systems for the treatment of diseases, such as tuberculosis (TB), has been widely explored. The current study investigated t...

of 14

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923